The Latest: UK OKs resumption of hydroxychloroquine trial
|
June 30, 2020 2:27 AM
LONDON — Britain’s medical regulatory agency has approved the resumption of a trial testing whether hydroxychloroquine, the malaria drug favored by U.S. President Donald Trump, might help prevent health workers from contracting the coronavirus.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
